{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:00Z","timestamp":1787022420714,"version":"build-2736575974"},"reference-count":20,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1507\/endocrj.k10e-156","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T01:20:23Z","timestamp":1282180823000},"page":"853-861","source":"Crossref","is-referenced-by-count":80,"title":["Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy"],"prefix":"10.1507","volume":"57","author":[{"given":"Seigo","family":"Tachibana","sequence":"first","affiliation":[{"name":"Department of Endoclinology, Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Endoclinology, Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Endoclinology, Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Radiology, Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufuko","family":"Ohyabu","sequence":"additional","affiliation":[{"name":"Kitahama eye clinic, Oita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Curro N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marino M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM (2008) Consensus statement of the European Group on Graves&rsquo; orbitopathy (EUGOGO) on management of GO. <i>Eur J Endocrinol <\/i>158: 273-285.","DOI":"10.1530\/EJE-07-0666"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves&rsquo; ophthalmopathy: a novel approach. <i>Br J Ophthalmol <\/i>73: 639-644.","DOI":"10.1136\/bjo.73.8.639"},{"key":"3","unstructured":"3. Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. <i>Clin Endocrinol (Oxf) <\/i>55: 283-303."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hiromatsu Y, Kojima K, Ishisaka N, Tanaka K, Sato M, Nonaka K, Nishimura H, Nishida H (1992) Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. <i>Thyroid <\/i>2: 299-305.","DOI":"10.1089\/thy.1992.2.299"},{"key":"5","unstructured":"5. Kirsch E, Hammer B, von Arx G (2009) Graves&rsquo; orbitopathy: current imaging procedures. <i>Swiss Med Wkly <\/i>139: 618-623."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ohnishi T, Noguchi S, Murakami N, Tajiri J, Harao M, Kawamoto H, Hoshi H, Jinnouchi S, Futami S, Nagamachi S, Watanabe K (1994) Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements. <i>Radiology <\/i>190: 857-862.","DOI":"10.1148\/radiology.190.3.8115640"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1089\/105072502753600179"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gerding MN, Prummel MF, Wiersinga WM (2000) Assessment of disease activity in Graves&rsquo; ophthalmopathy by orbital ultrasonography and clinical parameters. <i>Clin Endocrinol (Oxf) <\/i>52: 641-646.","DOI":"10.1046\/j.1365-2265.2000.00973.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gerding MN, van der Zant FM, van Royen EA, Koornneef L, Krenning EP, Wiersinga WM, Prummel MF (1999) Octreotide-scintigraphy is a disease-activity parameter in Graves&rsquo; ophthalmopathy. <i>Clin Endocrinol (Oxf) <\/i>50: 373-379.","DOI":"10.1046\/j.1365-2265.1999.00681.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Donaldson SS, Bagshaw MA, Kriss JP (1973) Supervoltage orbital radiotherapy for Graves&rsquo; ophthalmopathy. <i>J Clin Endocrinol Metab <\/i>37: 276-285.","DOI":"10.1210\/jcem-37-2-276"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.2331047.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kirsch EC, Kaim AH, De Oliveira MG, von Arx G (2010) Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves&rsquo; orbitopathy-a pilot study at 1.5 T. <i>Neuroradiology <\/i>52: 91-97.","DOI":"10.1007\/s00234-009-0590-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mayer E, Herdman G, Burnett C, Kabala J, Goddard P, Potts MJ (2001) Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease. <i>Eye (Lond) <\/i>15: 313-318.","DOI":"10.1038\/eye.2001.102"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mayer EJ, Fox DL, Herdman G, Hsuan J, Kabala J, Goddard P, Potts MJ, Lee RW (2005) Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. <i>Eur J Radiol <\/i>56: 20-24.","DOI":"10.1016\/j.ejrad.2005.03.027"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Just M, Kahaly G, Higer HP, Rosler HP, Kutzner J, Beyer J, Thelen M (1991) Graves ophthalmopathy: role of MR imaging in radiation therapy. <i>Radiology <\/i>179: 187-190.","DOI":"10.1148\/radiology.179.1.2006276"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Galuska L, Leovey A, Szucs-Farkas Z, Szabados L, Garai I, Berta A, Balazs E, Varga J, Nagy EV (2005) Imaging of disease activity in Graves&rsquo; orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores. <i>Nucl Med Commun <\/i>26: 407-414.","DOI":"10.1097\/00006231-200505000-00003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Saber E, McDonnell J, Zimmermann KM, Yugar JE, Feldon SE (1996) Extraocular muscle changes in experimental orbital venous stasis: some similarities to Graves&rsquo; orbitopathy. Graefes Arch <i>Clin Exp Ophthalmol <\/i>234: 331-336.","DOI":"10.1007\/BF00220709"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. de Juan E, Jr., Hurley DP, Sapira JD (1980) Racial differences in normal values of proptosis. <i>Arch Intern Med <\/i>140: 1230-1231.","DOI":"10.1001\/archinte.1980.00330200106028"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tellez M, Cooper J, Edmonds C (1992) Graves&rsquo; ophthalmopathy in relation to cigarette smoking and ethnic origin. <i>Clin Endocrinol (Oxf) <\/i>36: 291-294.","DOI":"10.1111\/j.1365-2265.1992.tb01445.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tsai CC, Kau HC, Kao SC, Hsu WM (2006) Exophthalmos of patients with Graves&rsquo; disease in Chinese of Taiwan. <i>Eye (Lond) <\/i>20: 569-573.","DOI":"10.1038\/sj.eye.6701925"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/10\/57_K10E-156\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:53:57Z","timestamp":1618282437000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/10\/57_K10E-156\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k10e-156","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}